Paul Chipperton is President & CEO of Insight Medbotics Inc. (IMI). Paul’s experience with early-stage MR-guided cancer companies is best evidenced as former co-founder & CEO of Profound Medical Inc. (NASDAQ:prof), where in the first 4-years of operations he raised >$16M of venture investment and initiated clinical trials and strategic partnerships with leading MRI companies. ​

Paul currently serves as a board member for Angel Investors Ontario (AIO), Fero International, and NorthEastern University’s (Boston, US) MSc Regulatory Affairs and MSc Biotechnology program advisory committees. ​

A passionate educator for >10-years, he still lectures weekend MBA/MSc/MHSc courses at several universities. At Queen’s University he also served a term as Senator. He received a BSc Hons Applied Chemistry from Northumbria University, Newcastle; and latterly an MBA from McGill.​